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Abstract
Background
We evaluated the use of a novel High Density Mesh Ablator (HDMA) catheter in combination with
three-dimensional navigation for the treatment of paroxysmal atrial fibrillation.
Methods
The HDMA catheter was used to carry out pulmonary vein isolation in a consecutive series of patients.
Three-dimensional geometry of the left atrial-pulmonary vein (LA-PV) junctions were first created with
the HDMA catheter. Ostial, proximal and distal sites within the pulmonary veins were tagged with
catheter shadows on the created geometry to allow for re-interrogation of these exact sites after ablation.
Results
The HDMA catheter was successfully used to create three dimensional geometry of the LA-PV junction in a total of 20 pulmonary veins which involved 5 patients. In all cases, ostial ablation alone was
sufficient to achieve electrical isolation. No significant pulmonary vein stenosis was seen acutely after
ablation.
Conclusion
We describe the successful use of the novel HDMA catheter to create three-dimensional geometry of the
LA-PV junction to assist with pulmonary vein isolation.
Keywords : Atrial Fibrillation, pulmonary vein isolation, ablation

Introduction
Since it was first described by Haissaguerre and
colleagues,1, 2 catheter ablation of atrial fibrillation

(AF) has become an important treatment option
inthe management of this common arrhythmia.
Then very first ablation procedures 2 described
made use of conventional catheters with radio-
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frequency (RF) energy to deliver lesions pointby-point at sites at the left atrial-pulmonary vein
(LA-PV) junction, aiming to isolate atrio-venous
and venoatrial conduction i.e. pulmonary vein
isolation.

density array of wires arranged in 2 helices to form
a mesh geometry, carrying a total of 36 electrodes.
It is designed to provide high density mapping of
the LA-PV junction by being able to conform to different shapes to suit any variation in anatomy. In
its low profile configuration, it is able to enter and
interrogate within the pulmonary vein itself. In its
fully deployed and expanded profile, it adopts a
circular, disc shape (30 mm diameter) to fit securely around the pulmonary vein ostium or antral region (Figure 1). It is non-steerable, and is capable
of simultaneous delivery of pulsed RF energy at
5ms cycles alternating between its even and odd
electrodes to achieve circumferential pulmonary
vein ablation. The array of wires is divided into 4
quadrants with a thermocouple at each quadrant
to allow for energy delivery under temperature
control.

Attempts to improve endocardial ablation efficacy have resulted in modifications to RF energy delivery with the use of irrigated catheter tips 3, 4 and
also application of pulsed RF energy 5. Alternative
energy sources that have been explored include
cryotherm6, microwave 7, laser8 and ultrasound .9
To simplify and improve the efficacy of pulmonary vein isolation, several studies have evaluated
different energy sources with novel catheter designs. Natale et al reported on the successful use
of a through-the-balloon delivery of ultrasound
energy for isolation of pulmonary veins .10 Results
of ablation using a high intensity focused ultrasound balloon catheter have also been recently
reported 11 Endoscopic visualization to assist laser energy delivery through a balloon catheter is
another technology that is currently being evaluated. 12, 13

All procedures were carried out with the use of local anaesthesia under conscious sedation. Bilateral
femoral venous access was used in all cases. Under
fluoroscopic guidance, a steerable decapolar catheter and quadripolar catheter were positioned in
the coronary sinus and His position respectively.

Recently, an expandable multi-electrode HDMA
catheter (High Density Mesh Ablator Catheter,
Bard Electrophysiology, Lowell, MA, USA) was
introduced as a one catheter solution to both
mapping and ablation of the LA-PV junction with
the use of pulsed RF energy. While it is possible to
use the HDMA catheter with fluoroscopic guidance only, the addition of three-dimensional (3D) navigation and mapping can provide further
anatomical information to help guide catheter
positioning and ensure delivery of ablation to optimal sites. We hereby describe our technique of
using this new ablation catheter in combination
with a 3-D navigation and mapping system, with
the aim of assessing the technical aspects of using
this catheter in this context, and at the same time
evaluating acute results achieved with it.

After baseline electrophysiology study, a single
transseptal puncture was carried out using a steerable 9F transseptal sheath (Channel sheath, Bard
Electrophysiology, Lowell, MA, USA) to gain access to the left atrium. Following pulmonary vein
angiography, the HDMA catheter was advanced
into the left atrium via the transseptal sheath. 3D geometry of the pulmonary veins and the left
atrium were created using the Ensite NavX system
version 7.0 (St. Jude Medical Inc, St. Paul, Minnesota USA) by moving the HDMA catheter, focusing
on the pulmonary vein antral and ostial regions.
The HDMA catheter was semi-deployed to enter
the pulmonary veins with gradual deployment allowing contact with the pulmonary vein wall on
pull-back whilst the ostial / antral / atrial geometry
was created with the catheter fully deployed as a
circular disc. Due care was taken to ensure that the
HDMA catheter was lined up with the long axis
of the pulmonary vein to facilitate ease of deployment. This was done by first keeping the HDMA
catheter in the transseptal sheath, before cannulating the pulmonary vein with the steerable sheath.
The HDMA catheter was then advanced to the
tip of the sheath, and gradual withdrawal of the

Methods
The HDMA catheter was used in a consecutive series of patients who had been referred for catheter
ablation of paroxysmal AF. All antiarrhythmic
therapies were discontinued for more than 5 halflives prior to the procedure.
The HDMA catheter utilizes an expandable high
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sheath was then carried out to expose the HDMA
catheter in the vein, which then allowed for pullback and formation of its circular disc-shaped
configuration. As the main areas of interest were
around the LA-PV junctions, only limited left
atrial wall geometry was created (Figure 2). A
unipolar catheter that was actively fixed in the
right atrium was used as reference for the geometry. Electrical signals were then recorded from
proximal and distal sites within each pulmonary
vein as well as at the pulmonary vein ostia using the HDMA catheter, during atrial pacing
from the distal coronary sinus electrodes. Each
of these sites were tagged by application of a
catheter shadow on the 3-D geometry (Figure
3). Once the HDMA catheter was deployed at
the LA-PV junction, RF energy was applied using a pulsed RF generator (Tempulse pulsed RF
controller, Bard Electrophysiology, Lowell, MA,
USA). Each application of energy continued for a
total duration of 300 seconds whenever possible,
aiming for a maximum target temperature of
58°C, with up to 100 W power output. Satisfactory contact with tissue was maintained by gentle
pressure on the catheter or sheath. After ablation, mapping was carried out at each pulmonary vein at previously tagged ostial, proximal
and distal sites as guided by the stored catheter
shadows on the 3-D geometry to confirm pul-

monary vein isolation. The endpoint of ablation
for each vein was elimination of all sharp signals
(either in the pulmonary veins or at the ostia) suggestive of atrio-venous connection as mapped
by the HDMA catheter. Electrical isolation was
considered to have been achieved if there was
evidence of entrance block or if dissociated pulmonary vein firing was seen 13 Before ablation of
the right sided pulmonary veins, pacing from the
electrodes on the HDMA catheter was carried out
to exclude any diaphragmatic stimulation. If this
was evident, the HDMA catheter is rotated and
re-orientated into a new position while ensuring
adequate endocardial contact and repeat stimulation carried out. This manoeuvre is repeated until
diaphragmatic stimulation was no longer possible.
In our experience this is usually adequate to prevent phrenic nerve injury, which was not seen in
any of the patients presented here. Pacing manoeuvres 14, 15 (using a steerable decapolar catheter in the
left atrium) were also used to differentiate far-field
atrial signals from local conduction when checking
for pulmonary vein isolation. This was achieved
by replacing the decapolar catheter with the quadripolar His catheter in the coronary sinus, followed
by advancement of the decapolar catheter into the
left atrium through the existing trannsseptal access. Once all pulmonary veins had been isolated,
repeat pulmonary vein angiography in the same

Figure 1: Fluoroscopic image of the HDMA catheter deployed at the left upper pulmonary vein (left anterior oblique view) via a
steerable transseptal sheath. A steerable decapolar catheter has been advanced into the left atrium and a quadripolar catheter
is in the coronary sinus. A photograph of the catheter in its low (A) and expanded (B) profile is shown in the inset.
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views was performed to assess for pulmonary vein
stenosis. Heparin was administered throughout
the procedure to maintain an activated clotting
time of around 300s. All electrograms were recorded on an electrophysiology review and recording
workstation (Labsystem pro, Bard Electrophysiology, Lowell, MA, USA).
All continuous variables are expressed as mean ±
standard deviation. Normally distributed paired
data were analysed using paired Student’s t-test.
Full consent for the procedure was obtained in all
patients.

Results
A total of 20 pulmonary veins in 5 patients were
ablated with the HDMA catheter (Table 1). High
density mapping and 3-D pulmonary vein and
limited left atrial geometry creation with the
HDMA catheter were successfully carried out in
every patient. No pulmonary venous anomaly or
common ostia were noted in any of the patients.
All patients had a history of paroxysmal AF and
mean left atrial dimensions on echocardiography

was 40 ± 5 mm, measured in the parasternal long
axis view; all patients were in sinus rhythm at
the start of the procedure. One patient developed
sustained AF during catheter manipulation in the
atrium but this reverted to sinus rhythm during
circumferential pulmonary vein ablation. All 20
pulmonary veins were successfully isolated. The
number of energy applications per patient was
13.6 ± 4.2 and durtion of total energy delivered
was 3093 ± 622 s. Number of energy applications
per vein was 3.4 ± 1.05 and duration of energy application per vein was 773 ± 156 s. Two patients
developed transient bradycardia and lowering of
blood pressure consistent with a significant vagal
response during ablation of the left upper pulmonary veins but this resolved without the need for
specific intervention. Mean fluoroscopy time was
68 ± 97 minutes and procedureduration was 286
± 30 minutes. Pulmonary vein ostial dimensions
before and after ablation showed no statistical difference when comparing measurements obtained
from fluoroscopy (Table 2).
In all cases, pulmonary vein signals which were
mapped and tagged at proximal and distal por-

Figure 2: High density 3-D geometry of the LA-PV junctions (with limited LA geometry) created with the HDMA
catheter using Ensite NavX. The left atrial appendage is labelled LAA and the pulmonary veins are shown as grids.
HDMA catheter shadows in the left upper pulmonary vein (LUPV) and its ostium indicate sites mapped by the catheter
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tions of each pulmonary vein, were completely
abolished after delivery of pulsed RF energy with
the HDMA catheter at the pulmonary ostia alone.
Examples of intracardiac signals before and after
pulmonary vein isolation are shown in Figure 4.
Apart from minor groin haematoma in 1 patient,
no other significant procedure-related complications were encountered acutely in patients reported in this study.
At the time of writing, 4 out of the 5 patients reported in this series had reported significant
symptomatic improvement and were free of AF
as assessed by routine 24 hour Holter monitoring
more than 3 months after the ablation (3 off antiarrhythmic medication). One patient had documented recurrence of symptomatic, paroxysmal
AF at 3 months post-procedure. No long term
procedure-related complications were encountered. Mean duration of follow-up for all patients
was 112 ± 19 days.

Discussion
We have hereby described our technique of using
the novel High Density Mesh Ablator catheter in

conjunction with 3-D navigation and mapping
using the Ensite NavX system. While the catheter
has been developed with the intention for it to be
used as a single mapping and ablation catheter for
pulmonary vein isolation without employing 3-D
mapping assistance, the HDMA catheter is still a
relatively new product and published experience
of its use in humans is limited. In our group of patients, we successfully used the HDMA catheter
to create high density 3-D geometries of the pulmonary veins and the ostial / antral regions to
help guide catheter manipulation and also to recheck specific sites in and around the pulmonary
veins when assessing for electrical isolation. Although not encountered in our series, 3-D navigation will be especially useful in the delineation
of any anomalous venous anatomy or common
ostia which may limit the ability of the catheter
to deliver effective lesions at desired sites. This is
particularly relevant as the shape of the expanded
HDMA catheter is designed to fit normal pulmonary venous ostia and could have difficulty conforming to anatomical variation. Having a 3-D geometry will help guide positioning of the HDMA
catheter. In all cases, ablation was limited to only
to the LA- PV junction as non-pulmonary vein

Figure 3: HDMA catheter shadows marking ostial, proximal and distal left upper pulmonary vein (top) and demonstration
of lesions delivered by the HDMA catheter (bottom)
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triggers of AF were not encountered in any of the
patients. While the HDMA catheter is capable of
ablation around pulmonary vein ostial and antral
regions, we expect that ablation of non-pulmonary
vein foci remote from the LA-PV junction will require the use of standard ablation catheters. These,

however, have previously been shown to occur
less frequently than pulmonary vein triggers .2
The risk of pulmonary vein stenosis is reduced
by ablating at the ostium or antral region rather
than within the vein. 18, 19 The further the abla-

Figure 4: Left lower pulmonary vein ostium (a), proximal vein (b), and distal vein (c) signals mapped from odd-numbered electrode pairs of the HDMA catheter before (left panel) and after (right panel) ablation, during distal coronary sinus pacing. The
remaining electrical signals seen at the ostium after ablation were found to be from far-field sites by using pacing manoeuvres.
Corresponding locations on the 3-D geometry are shown in the bottom panel.
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tioncatheter is placed from the pulmonary vein,
the lower the risk of pulmonary vein stenosis. The
HDMA catheter was designed with this in mind
and its configuration in the expanded profile prevents the catheter from entering the vein, and ensures that all ablation is delivered from the atrial
aspect of the ostium. However, a potential problem
with circumferential pulmonary ostial ablation is
the persistence of LA-PV conduction. This would
not be detectable by mapping the ostium alone and
further interrogation within the pulmonary vein itself is desirable and often necessary. In our study
the use of 3-D navigation and geometry tagging to
mark proximal and distal pulmonary vein and ostial sites allowed these exact locations to be accurately re-visited and assessed post-ablation to ensure
complete isolation. Our experience so far, using
the above technique, indicates that ostial ablation
alone with the HDMA catheter to eliminate ostial
potentials can lead to successful isolation of the
pulmonary veins, without causing any significant
pulmonary venous stenosis. This is in agreement
Table 1

with a feasibility study of a similar HDMA catheter
carried out on canine hearts .20 where it was used to
successfully isolate the right superior pulmonary
vein, without causing any significant pulmonary
venous stenosis on both post-ablation and also on
follow-up pulmonary vein angiography.

Limitations
This report consists of a small number of patients
with short term follow-up. However, we would
like to stress that the intention of this paper is to
document the feasibility of combining the HDMA
catheter with 3-D navigation and mapping, and to
highlight the possible advantages of such an approach. As this is a description of our early experience using the HDMA catheter, a considerable
amount of time was spent on setting up equipment,
manipulating the catheter, and also checking for
pulmonary vein isolation. This will account for the
fluoroscopy time and also overall procedure time
reported in this study. With more operator experi-

Procedural details of each patien

Patient No.

Left Atrial
Size (mm)

No. of
pulmonary
veins isolated

Total RF
delivery time
(s)

Fluoroscopy
time (minutes)

Total
procedure
time
(minutes)

1

35

4

3417

66.7

325

2

47

4

3756

82.2

300

3

37

4

3296

73.6

290

4

42

4

2860

62.0

245

5

41

4

2138

57.5

270

Table 2

Comparison of pulmonary vein ostial dimensions on fluoroscopy pre- and post-ablation with the HDMA
catheter (all measurements are in mm)

Patient
No.

Pre-Ablation

Post-Ablation

LUPV

LLPV

RUPV

RLPV

LUPV

LLPV

RUPV

RLPV

1

16

23

25

12

16

21

22

13

2

28

24

34

28

27

24

30

27

3

24

28

19

14

23

26

16

12

4

30

24

29

26

29

24

29

24

5

30

20

27

18

24

20

27

14

Mean

25.6*

23.8†

26.8‡

19.6ş

23.8*

23.0†

25.6‡

18.2ş

*P = 0.17, †P = 0.18, ‡P = 0.11, şP = 0.13
LUPV = Left upper pulmonary vein, LLPV = Left lower pulmonary vein, RUPV = Right
upper pulmonary vein, RLPV = Right lower pulmonary vein
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ence and familiarity, it is anticipated that the procedure time would be significantly reduced.

Conclusion
We have demonstrated that pulmonary vein isolation can be carried out with the HDMA catheter
in combination with 3-D navigation to create high
density three-dimensional geometry of the LA-PV
junction, and that this can assist with catheter
placement and confirmation of pulmonary vein
isolation. Using this technique, the HDMA catheter is capable of circumferential ostial isolation
of the pulmonary veins without causing significant
pulmonary vein stenosis acutely on angiography.
Our data serves as a favourable feasibility
assessment of the above technique and further
evaluation of its safety and efficacy in a larger cohort of patients should be performed
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